Works matching DE "ORAL therapy for diabetes"
Results: 136
Good control and few hypos possible with basal insulin starts.
- Published in:
- Practice Nursing, 2009, v. 20, n. 12, p. 590, doi. 10.12968/pnur.2009.20.12.45578
- Publication type:
- Article
Desktop software to identify patients eligible for recruitment into a clinical trial: using SARMA to recruit to the ROAD feasibility trial.
- Published in:
- Informatics in Primary Care, 2010, v. 18, n. 1, p. 51
- By:
- Publication type:
- Article
Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.
- Published in:
- Diabetic Medicine, 2010, v. 27, n. 2, p. 136, doi. 10.1111/j.1464-5491.2009.02894.x
- By:
- Publication type:
- Article
MEASURE IT, IMPROVE IT: the Safer Patients Initiative and quality improvement in subcutaneous insulin therapy for hospital in-patients.
- Published in:
- Diabetic Medicine, 2008, v. 25, n. 8, p. 960, doi. 10.1111/j.1464-5491.2008.02470.x
- By:
- Publication type:
- Article
Perinatal outcomes associated with the use of glargine during pregnancy.
- Published in:
- Diabetic Medicine, 2008, v. 25, n. 8, p. 993, doi. 10.1111/j.1464-5491.2008.02485.x
- By:
- Publication type:
- Article
The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera® as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial
- Published in:
- Diabetic Medicine, 2008, v. 25, n. 6, p. 662, doi. 10.1111/j.1464-5491.2008.02438.x
- By:
- Publication type:
- Article
A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2007, v. 24, n. 6, p. 618, doi. 10.1111/j.1464-5491.2007.02141.x
- By:
- Publication type:
- Article
Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care.
- Published in:
- Diabetic Medicine, 2007, v. 24, n. 4, p. 350, doi. 10.1111/j.1464-5491.2007.02078.x
- By:
- Publication type:
- Article
Oral Communications.
- Published in:
- Diabetic Medicine, 2006, v. 23, p. 208, doi. 10.1111/j.1464-5491.2006.02037_6.x
- Publication type:
- Article
Effect of a pocket-size tablet-dispensing device on glycaemic control in Type 2 diabetic patients.
- Published in:
- Diabetic Medicine, 2006, v. 23, n. 1, p. 40, doi. 10.1111/j.1464-5491.2005.01721.x
- By:
- Publication type:
- Article
Lack of pharmacokinetic interaction for ISIS 113715, a 2'-0-methoxyethyl modified antisense oligonucleotide targeting protein tyrosine phosphatase 1B messenger RNA, with oral antidiabetic compounds metformin, glipizide or rosiglitazone.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Dentists' Management of the Diabetic Patient: Contrasting Generalists and Specialists.
- Published in:
- American Journal of Public Health, 2007, v. 97, n. 4, p. 725, doi. 10.2105/AJPH.2006.086496
- By:
- Publication type:
- Article
Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans.
- Published in:
- 2017
- By:
- Publication type:
- journal article
β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy.
- Published in:
- Diabetes Care, 2012, v. 35, n. 7, p. 1406, doi. 10.2337/dc11-2170
- By:
- Publication type:
- Article
Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 3, p. 295, doi. 10.1007/s00592-017-1072-0
- By:
- Publication type:
- Article
Acute esophageal necrosis (black esophagus): a case report and literature review.
- Published in:
- Acta Diabetologica, 2017, v. 54, n. 11, p. 1061, doi. 10.1007/s00592-017-1028-4
- By:
- Publication type:
- Article
Improving diabetes care at primary care level with a multistrategic approach: results of the DIAPREM programme.
- Published in:
- Acta Diabetologica, 2017, v. 54, n. 9, p. 853, doi. 10.1007/s00592-017-1016-8
- By:
- Publication type:
- Article
Preprandial repaglinide decreases exogenous insulin requirements and HbA1c levels in type 2 diabetic patients taking intensive insulin treatment.
- Published in:
- Acta Diabetologica, 2006, v. 43, n. 4, p. 148, doi. 10.1007/s00592-006-0231-5
- By:
- Publication type:
- Article
Insulinization: A promising strategy for the treatment of type 2 diabetes mellitus.
- Published in:
- Experimental & Therapeutic Medicine, 2013, v. 6, n. 5, p. 1300, doi. 10.3892/etm.2013.1300
- By:
- Publication type:
- Article
Does periodontal care improve glycemic control? The Department of Veterans Affairs Dental Diabetes Study.
- Published in:
- British Dental Journal, 2007, v. 203, n. 1, p. 36, doi. 10.1038/bdj.2007.590
- Publication type:
- Article
Long-Term Improvement of Metabolic Control by Acarbose in Type 2 Diabetes Patients Poorly Controlled with Maximum Sulfonylurea Therapy.
- Published in:
- Clinical Drug Investigation, 2003, v. 23, n. 10, p. 679, doi. 10.2165/00044011-200323100-00007
- By:
- Publication type:
- Article
Dental Health and Diabetes.
- Published in:
- Oral Health (0974-3960), 2013, v. 7, n. 1, p. 8
- Publication type:
- Article
Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2014, v. 7, p. 15, doi. 10.2147/DMSO.S38753
- By:
- Publication type:
- Article
Oral antidiabetic agents.
- Published in:
- Nursing Standard, 2005, v. 19, n. 36, p. 105
- By:
- Publication type:
- Article
Bacillus-produced surfactin for intranasal delivery of insulin in diabetic mice.
- Published in:
- International Journal of Diabetes in Developing Countries, 2018, v. 38, n. 3, p. 321, doi. 10.1007/s13410-017-0564-3
- By:
- Publication type:
- Article
A review of the mechanisms of oral tolerance and immunotherapy.
- Published in:
- Journal of the Royal Society of Medicine, 1995, v. 88, n. 1, p. 14
- By:
- Publication type:
- Article
Oral hypoglycemic agents in pregnancy.
- Published in:
- Contemporary OB/GYN, 2007, v. 52, n. 11, p. 38
- By:
- Publication type:
- Article
Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors.
- Published in:
- World Journal of Urology, 2005, v. 23, n. 6, p. 385, doi. 10.1007/s00345-005-0021-7
- By:
- Publication type:
- Article
Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005.
- Published in:
- Diabetologia, 2006, v. 49, n. 2, p. 253, doi. 10.1007/s00125-005-0107-1
- By:
- Publication type:
- Article
Metformin and Risk of Cardiovascular Disease.
- Published in:
- Cardiology, 1999, v. 91, n. 3, p. 203, doi. 10.1159/000006910
- By:
- Publication type:
- Article
Atorvastation fails to demonstrate significant benefit in treatment of CV disease in patients with diabetes.
- Published in:
- Formulary, 2006, v. 41, n. 9, p. 463
- Publication type:
- Article
Titration and optimization trial for the initiation of insulin glargine 100 U/mL in patients with inadequately controlled type 2 diabetes on oral antidiabetic drugs.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 439, doi. 10.1111/dom.13535
- By:
- Publication type:
- Article
Should sodium‐glucose co‐transporter‐2 inhibitors be considered as first‐line oral therapy for people with type 2 diabetes?
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 207, doi. 10.1111/dom.13518
- By:
- Publication type:
- Article
Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population‐based, propensity‐score‐matched cohort study
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 312, doi. 10.1111/dom.13525
- By:
- Publication type:
- Article
Higher mortality rate in patients with heart failure who are taking commonly prescribed antidiabetic medications and achieve recommended levels of glycaemic control.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1766, doi. 10.1111/dom.13265
- By:
- Publication type:
- Article
Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: <italic>Post‐hoc</italic> analysis of concomitant add‐on versus sequential add‐on to metformin and of triple versus dual therapy with metformin.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1542, doi. 10.1111/dom.13258
- By:
- Publication type:
- Article
A missense variant in GLP1R gene is associated with the glycaemic response to treatment with gliptins.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 9, p. 941, doi. 10.1111/dom.12682
- By:
- Publication type:
- Article
Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 9, p. 855, doi. 10.1111/dom.12688
- By:
- Publication type:
- Article
Combination statin–fibrate therapy: safety aspects.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 2, p. 89, doi. 10.1111/j.1463-1326.2008.00917.x
- By:
- Publication type:
- Article
Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 2, p. 150, doi. 10.1111/j.1463-1326.2008.00933.x
- By:
- Publication type:
- Article
Sodium–glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 2, p. 79, doi. 10.1111/j.1463-1326.2008.00982.x
- By:
- Publication type:
- Article
Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2008, v. 10, n. 12, p. 1167, doi. 10.1111/j.1463-1326.2008.00907.x
- By:
- Publication type:
- Article
Nateglinide, alone or in combination with metformin, is effective and well tolerated in treatment-naïve elderly patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2008, v. 10, n. 8, p. 652, doi. 10.1111/j.1463-1326.2007.00792.x
- By:
- Publication type:
- Article
Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2006, v. 8, n. 1, p. 39, doi. 10.1111/j.1463-1326.2005.00492.x
- By:
- Publication type:
- Article
Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study.
- Published in:
- Diabetes, Obesity & Metabolism, 2006, v. 8, n. 1, p. 49, doi. 10.1111/j.1463-1326.2005.00541.x
- By:
- Publication type:
- Article
Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when added at an advanced stage of type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2006, v. 8, n. 1, p. 110, doi. 10.1111/j.1463-1326.2005.00560.x
- By:
- Publication type:
- Article
Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
- Published in:
- Diabetes, Obesity & Metabolism, 2006, v. 8, n. 1, p. 58, doi. 10.1111/j.1463-1326.2005.00563.x
- By:
- Publication type:
- Article
Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients.
- Published in:
- Current Medical Research & Opinion, 2010, v. 26, n. 8, p. 2003, doi. 10.1185/03007995.2010.491266
- By:
- Publication type:
- Article
Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
- Published in:
- Current Medical Research & Opinion, 2009, v. 25, n. 11, p. 2643
- By:
- Publication type:
- Article